
|Videos|April 28, 2022
Findings help investigators understand how FDA-approved AGN-19058 behaves
Author(s)Kassi Filkins
George Waring, MD, discusses the findings of a retrospective study on Allergan’s AGN-190584 for the treatment of presbyopia.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: A new biomechanical paradigm for presbyopia
2
AAO 2025 Takeaways: Cornea, refractive surgery, and aesthetics redefined
3
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
4
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
5

















































.png)


